Zurich Cantonal Bank
DRNA

Zurich Cantonal Bank’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Zurich Cantonal Bank’s Portfolio DRNA Stock Details DRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-7,465
Closed -$150K – 2959
2021
Q3 		$150K Sell
7,465
-1,032
-12% -$28.5K ﹤0.01% 2103
2021
Q2 		$317K Buy
8,497
+1,032
+14% +$31.6K ﹤0.01% 1507
2021
Q1 		$191K Sell
7,465
-1,279
-15% -$32.7K ﹤0.01% 1805
2020
Q4 		$193K Buy
8,744
+1,698
+24% +$37.4K ﹤0.01% 1871
2020
Q3 		$127K Hold
7,046
– – ﹤0.01% 1878
2020
Q2 		$179K Buy
7,046
+2,555
+57% +$55K ﹤0.01% 1587
2020
Q1 		$82K Buy
4,491
+1,128
+34% +$21.9K ﹤0.01% 1716
2019
Q4 		$74K Hold
3,363
– – ﹤0.01% 1915
2019
Q3 		$48K Buy
3,363
+1,151
+52% +$16.5K ﹤0.01% 2085
2019
Q2 		$35K Hold
2,212
– – ﹤0.01% 2263
2019
Q1 		$32K Sell
2,212
-1,247
-36% -$14.3K ﹤0.01% 2246
2018
Q4 		$37K Buy
3,459
+2,894
+512% +$38.1K ﹤0.01% 2204
2018
Q3 		$9K Buy
+565
New +$8.22K ﹤0.01% 2553

Other funds holding DRNA

CAM
Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Zurich Cantonal Bank's DRNA Position: Q4 2021 in Review

Zurich Cantonal Bank sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 7,465 shares — an estimated $150K sold.

Zurich Cantonal Bank first reported a position in DRNA in Q3 2018 and held it in 13 quarters. The position peaked at $317K in Q2 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

  • Zurich Cantonal Bank reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
  • Zurich Cantonal Bank sold 7,465 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $150K.
  • Zurich Cantonal Bank first reported a position in Dicerna Pharmaceuticals, Inc. in Q3 2018 and held it in 13 quarters.
  • Zurich Cantonal Bank's Dicerna Pharmaceuticals, Inc. position peaked at $317K in Q2 2021.
  • 1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on Zurich Cantonal Bank's 13F filing for Q4 2021, filed 1 Feb 2022.